Author Index
Search or browse for an author across our entire electronic archive
Search results for: K
Results 71 - 80 of 1824 shown below
Kaibara, N
H Andachi, K Yashima, M Koda, K Kawaguchi, A Kitamura, A Hosoda, Y Kishimoto, G Shiota, H Ito, M Makino, N Kaibara, H Kawasaki and Y Murawaki
Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma
doi:10.1038/sj.bjc.6600501
Abstract | Full article | PDF
-
M Ikeguchi and N Kaibara
survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma
doi:10.1038/sj.bjc.6600546
Abstract | Full article | PDF
-
H Saito, S Tsujitani, S Oka, A Kondo, M Ikeguchi, M Maeta and N Kaibara
The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma
doi:10.1038/sj.bjc.6690719
Kaibuchi, K
S Miyamoto, H Baba, S Kuroda, K Kaibuchi, T Fukuda, Y Maehara and T Saito
Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer
doi:10.1054/bjoc.2000.1386
Kaijen, P
A Claeskens, N Ongenae, J M Neefs, P Cheyns, P Kaijen, M Cools and E Kutoh
Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation
doi:10.1054/bjoc.1999.1051
Kaijser, M
M Kaijser, O Akre, S Cnattingius and A Ekbom
Preterm birth, birth weight, and subsequent risk of female breast cancer
doi:10.1038/sj.bjc.6601357
Abstract | Full article | PDF
Kailash, U
U Kailash, C C Soundararajan, R Lakshmy, R Arora, S Vivekanandhan and B C Das
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
advance online publication, 2006-10-24 00:00:00.000;
doi:10.1038/sj.bjc.6603375
Abstract | Full article | PDF
Kaina, B
R Becker, A Ritter, U Eichhorn, J Lips, B Bertram, M Wiessler, M Z Zdzienicka and B Kaina
Induction of DNA breaks and apoptosis in crosslink-hypersensitive V79 cells by the cytostatic drug
-D-glucosyl-ifosfamide mustarddoi:10.1038/sj.bjc.6600027
Abstract | Full article | PDF
-
G Fritz, C Brachetti, F Bahlmann, M Schmidt and B Kaina
Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters
doi:10.1038/sj.bjc.6600510
Abstract | Full article | PDF
-
S C Naumann, W P Roos, E Jöst, C Belohlavek, V Lennerz, C W Schmidt, M Christmann and B Kaina
Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53
advance online publication, 2009-01-06 00:00:00.000;
doi:10.1038/sj.bjc.6604856
Abstract | Full article | PDF
-
H Seker, B Bertram, A Bürkle, B Kaina, J Pohl, H Koepsell and M Wie
lerMechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent
doi:10.1054/bjoc.1999.0974
Kainu, T
K Rapakko, M Allinen, K Syrjäkoski, P Vahteristo, P Huusko, K Vähäkangas, H Eerola, T Kainu, O-P Kallioniemi, H Nevanlinna and R Winqvist
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
doi:10.1054/bjoc.2000.1530
Kainulainen, T
S Hamidi, T Salo, T Kainulainen, J Epstein, K Lerner and H Larjava
Expression of
v
6integrin in oral leukoplakiadoi:10.1054/bjoc.1999.1130
Kainz, C
M Boogaerts, B Coiffier and C Kainz
Impact of epoetin
on quality of life in patients with malignant diseasedoi:10.1038/sj.bjc.6600801
Abstract | Full article | PDF
-
L Hefler, C Tempfer, G Heinze, K Mayerhofer, G Breitenecker, S Leodolter, A Reinthaller and C Kainz
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
doi:10.1038/sj.bjc.6690776
-
G H Windbichler, H Hausmaninger, W Stummvoll, A H Graf, C Kainz, J Lahodny, U Denison, E Müller-Holzner and C Marth
Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial
doi:10.1054/bjoc.1999.1053
Kaira, K
K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, S Tanaka, T Ishizuka, Y Kanai, H Endou, T Nakajima and M Mori
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
advance online publication, 2008-02-05 00:00:00.000;
doi:10.1038/sj.bjc.6604235
Abstract | Full article | PDF
-
Result page:
- 1|
- 2|
- 3|
- 4|
- 5|
- 6|
- 7|
- 8|
- 9|
- 10|
- 11|
- 12|
- 13|
- 14|
- 15|
- 16|
- 17|
- 18|
- 19|
- 20|
- 21|
- 22|
- 23|
- 24|
- 25|
- 26|
- 27|
- 28|
- 29|
- 30|
- 31|
- 32|
- 33|
- 34|
- 35|
- 36|
- 37|
- 38|
- 39|
- 40|
- 41|
- 42|
- 43|
- 44|
- 45|
- 46|
- 47|
- 48|
- 49|
- 50|
- 51|
- 52|
- 53|
- 54|
- 55|
- 56|
- 57|
- 58|
- 59|
- 60|
- 61|
- 62|
- 63|
- 64|
- 65|
- 66|
- 67|
- 68|
- 69|
- 70|
- 71|
- 72|
- 73|
- 74|
- 75|
- 76|
- 77|
- 78|
- 79|
- 80|
- 81|
- 82|
- 83|
- 84|
- 85|
- 86|
- 87|
- 88|
- 89|
- 90|
- 91|
- 92|
- 93|
- 94|
- 95|
- 96|
- 97|
- 98|
- 99|
- 100|
- 101|
- 102|
- 103|
- 104|
- 105|
- 106|
- 107|
- 108|
- 109|
- 110|
- 111|
- 112|
- 113|
- 114|
- 115|
- 116|
- 117|
- 118|
- 119|
- 120|
- 121|
- 122|
- 123|
- 124|
- 125|
- 126|
- 127|
- 128|
- 129|
- 130|
- 131|
- 132|
- 133|
- 134|
- 135|
- 136|
- 137|
- 138|
- 139|
- 140|
- 141|
- 142|
- 143|
- 144|
- 145|
- 146|
- 147|
- 148|
- 149|
- 150|
- 151|
- 152|
- 153|
- 154|
- 155|
- 156|
- 157|
- 158|
- 159|
- 160|
- 161|
- 162|
- 163|
- 164|
- 165|
- 166|
- 167|
- 168|
- 169|
- 170|
- 171|
- 172|
- 173|
- 174|
- 175|
- 176|
- 177|
- 178|
- 179|
- 180|
- 181|
- 182|
- 183|
- Next
